News & Media
News Articles
Winnipeg Chamber of Commerce Receives Funding Boost Under the Canada-Manitoba Economic Partnership Agreement
Winnipeg and the Province of Manitoba will benefit from an initiative to increase local economic activity, thanks to $280,000 in support from the Governments of Canada and Manitoba.
Cangene announces highest-ever financial results for fiscal 2009
Cangene Corporation today reports financial results for the fiscal year ended July 31, 2009.
Kane Biotech selected to Present at Biomedical Defence Conference in Washington, DC
Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms is pleased to announce that the Company has been selected to present at the Partners in Biomedical Defence 2009 Conf
DispersinB® Topical Wound Gel Manufacturing Completed
Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms is pleased to announce that BioVectra has successfully completed the manufacturing of DispersinB® Topical Wound Gel un
Kane Biotech Granted United States Patent for Oral Care Technology
Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms is pleased to announce the issuance of Patent No. 7,556,807 entitled “Signal peptides, nucleic acid molecules and me
Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society
Winnipeg-based medical device company Intelligent Hospital Systems (IH Systems) was awarded the 21st Century Achievement Award during the Computerworld Honors Program Awards Gala on June 1, 2009 in Washington D.C.
Medicure Announces Private Placement
Medicure Inc. ("Medicure" or the "Company") (TSX: MPH) announces its plan to raise up to $3.0 million to improve its financial position through a non-brokered private placement of common shares (the "Offering") at a price of $0.05 per common share.
Miraculins Completes Agreements with Diagnostic Technologies Ltd. and CIIRDF
Company to Receive $467,000 in Funding to Advance Risk Assessment Products for Preeclampsia
Ray of Hope for Cancer Patients
The technology, called the AutoLITT System, uses an MRI-guided laser probe, passed through a hole in the skull about the size of a dime, to deliver laser interstitial thermal therapy (LITT) to heat and coagulate the tumour from the inside.
Miraculins Announces Closing of $400,000 Private Placement Offering
Miraculins Inc. (TSX-V:MOM) (the “Company”), a company focused on developing and commercializing medical diagnostic tests for unmet clinical needs, has closed its previously announced private placement offering (the "Offering") with aggregate gross procee
IH Systems Extends Global Reach into South Korean Medical Device Market
Medical device company, Intelligent Hospital Systems (IH Systems), has entered into an agreement with the South Korean pharmacy application specialists, Daeiltech (www.daeiltech.co.kr), based in Seoul. Daeiltech will provide direct sales and service suppo
Kane Biotech Announces Private Placement Offering
Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms (the “Company”), today announces a non-brokered private placement offering (the “Offering”) for gross proceeds of up
Scientists Learning To Target Bacteria Where They Live
In the arms race between humans and bacteria, the ability to form "biofilms" -- large aggregations of microbes embedded in a slimy matrix -- has been one of the weapons the organisms use to defeat the immune system, antibiotic drugs and other threats. But
MGI Pharma vet takes DiaMedica reins
Reggie Bowerman saw the doors close at MGI Pharma Inc.’s former headquarters late last year. Now, he’s aiming to open some new doors in biotech for a Canadian startup setting up shop in Minnesota.
Australia’s Leading Oncology Drug Compounder Chooses RIVA System
Pharmatel Fresenius Kabi Pty Ltd, an innovative Australian pharmaceutical company, has chosen the RIVA System (Robotic IV Automation)-a self-contained unit for filling IV syringes and bags- from Intelligent Hospital Systems (IH Systems) to consolidate its
Miraculins Announces Improved Detection of Aggressive Prostate Cancer With Combination of PSP94 and Free Over Total PSA Ratio
Discovery Compliments New Approaches to Prostate Cancer Treatment
Kane Biotech Receives an Additional Contribution from NRC-IRAP to Develop its DispersinB® Antibiofilm Wound Gel Product
Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development of products that prevent and disperse microbial biofilms, is pleased to announce that the National Research Council Industrial Research Assistance Program (NRC-IRAP) has inc
Miraculins’ Completed P2V™ Immunoassay Confirms Mass Spectrometry Results
Company concludes research on prostate program and seeks licensing partner
Miraculins Announces Amendment to Private Placement Offering
Miraculins Inc. (TSX-V:MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, announces today an amendment to the terms of its private placement offering (the "Offering") announced on Novemb
LSAM Recognizes Leaders in the Life Science Sector
The Life Science Association of Manitoba (LSAM) awarded its annual Life Science Awards this week. Recognizing the leaders and innovators of the life science community, the awards highlight the great work being done in this growing and dynamic industry.